Updated:
Myriad Genetics
Myriad Genetics hereditary cancer, prenatal, oncology and mental health genetic testing insights can help detect, treat and prevent disease. Get started today.
Overview
Myriad Genetics hereditary cancer, prenatal, oncology and mental health genetic testing insights can help detect, treat and prevent disease. Get started today.
General information
Year founded
1991
Location
Region
North America
Country
United States
City
Salt Lake City
Corporate office
Salt Lake City, UT, United States
Sector focus
Frequently asked questions
What types of genetic tests does Myriad Genetics offer?
Myriad offers tests across five health areas: hereditary cancer risk (e.g., identifying risk of 11 hereditary cancers), reproductive health (carrier screening, prenatal aneuploidy), oncology (tumor genomic profiling for FDA-approved therapies), urology (prostate cancer aggressiveness), and mental health (pharmacogenomics for antidepressant response).
Who uses Myriad Genetics' tests?
Myriad's tests are used by oncologists, urologists, reproductive health specialists, and primary care providers. The company markets directly to patients and clinicians, emphasizing actionable results that guide treatment decisions.
Does Myriad Genetics have investment activities?
Myriad Genetics operates as a testing company, not an investment manager. It does not deploy capital as a family office or venture firm.
How does Myriad Genetics differentiate from other genetic testing companies?
Myriad holds a large comparative data repository covering all ancestries and offers tests across multiple specialties. It emphasizes test development grounded in its own data, rather than relying solely on third-party databases.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: